User: Guest  Login
Title:

Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)-Never Change a Running System?

Document type:
Article; Journal Article
Author(s):
Just, Katja S; Scholl, Catharina; Boehme, Miriam; Kastenmüller, Kathrin; Just, Johannes M; Bleckwenn, Markus; Holdenrieder, Stefan; Meier, Florian; Weckbecker, Klaus; Stingl, Julia C
Abstract:
The aim of this study was to compare effects of an individualized with a standardized risk assessment for adverse drug reactions to improve drug treatment with antithrombotic drugs in older adults. A randomized controlled trial was conducted in general practitioner (GP) offices. Patients aged 60 years and older, multi-morbid, taking antithrombotic drugs and at least one additional drug continuously were randomized to individualized and standardized risk assessment groups. Patients were followed...     »
Journal title abbreviation:
Pharmaceuticals (Basel)
Year:
2021
Journal volume:
14
Journal issue:
10
Fulltext / DOI:
doi:10.3390/ph14101056
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/34681280
TUM Institution:
Institut für Laboratoriumsmedizin (keine SAP-Zuordnung!)
 BibTeX